Literature DB >> 9659248

Apolipoprotein E alleles in women with severe pre-eclampsia.

B Nagy1, J Rigó, L Fintor, I Karádi, T Tóth.   

Abstract

This study investigated the frequency of apolipoprotein E (apoE) alleles among women with severe pre-eclampsia. The presence of the three most common apoE alleles (epsilon 2, epsilon 3, epsilon 4) was determined by polymerase chain reaction-restriction fragment length polymorphism in three groups of white women: non-pregnant healthy (n = 101), pregnant healthy (n = 52), and pregnant with a diagnosis of severe pre-eclampsia (n = 54). The frequency of apo epsilon 2 was highest among women with severe pre-eclampsia (16.6%) followed by non-pregnant women (12.9%), and those experiencing a healthy pregnancy (10.6%). The higher frequency of the apo epsilon 2 allele detected among women with severe pre-eclampsia suggests that apoE may play a role in the development of pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659248      PMCID: PMC500680          DOI: 10.1136/jcp.51.4.324

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  High levels of Lp(a) lipoprotein in a family with cases of severe pre-eclampsia.

Authors:  H Husby; B Roald; R Schjetlein; B I Nesheim; K Berg
Journal:  Clin Genet       Date:  1996-07       Impact factor: 4.438

2.  Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis.

Authors:  N Sattar; A Bendomir; C Berry; J Shepherd; I A Greer; C J Packard
Journal:  Obstet Gynecol       Date:  1997-03       Impact factor: 7.661

3.  Genotyping and sequence analysis of apolipoprotein E isoforms.

Authors:  M Emi; L L Wu; M A Robertson; R L Myers; R A Hegele; R R Williams; R White; J M Lalouel
Journal:  Genomics       Date:  1988-11       Impact factor: 5.736

4.  Determination by PCR-RFLP of apo E genotype in a Japanese population.

Authors:  K Tsukamoto; T Watanabe; T Matsushima; M Kinoshita; H Kato; Y Hashimoto; K Kurokawa; T Teramoto
Journal:  J Lab Clin Med       Date:  1993-04

5.  Rapid and safe determination of human apolipoprotein E genotypes by miniaturised SDS-PAGE in non-insulin dependent diabetes mellitus.

Authors:  C Clavel; A Durlach; V Durlach; P Birembaut
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

  5 in total
  9 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Apolipoprotein E polymorphisms and spontaneous pregnancy loss in patients with endometriosis.

Authors:  Madeline S Collazo; Tirtsa Porrata-Doria; Idhaliz Flores; Summer F Acevedo
Journal:  Mol Hum Reprod       Date:  2012-01-20       Impact factor: 4.025

3.  The distribution of apolipoprotein E alleles in Scottish perinatal deaths.

Authors:  J-C Becher; J W Keeling; N McIntosh; B Wyatt; J Bell
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

4.  Spontaneous superimposed preeclampsia: chronology and expression unveiled by temporal transcriptomic analysis.

Authors:  Kenji J Maeda; Kurt C Showmaker; Ashley C Johnson; Michael R Garrett; Jennifer M Sasser
Journal:  Physiol Genomics       Date:  2019-05-24       Impact factor: 3.107

5.  Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia.

Authors:  Hiten D Mistry; Lesia O Kurlak; Yosef T Mansour; Line Zurkinden; Markus G Mohaupt; Geneviève Escher
Journal:  J Lipid Res       Date:  2017-04-10       Impact factor: 5.922

Review 6.  Novel biomarkers for predicting preeclampsia.

Authors:  David M Carty; Christian Delles; Anna F Dominiczak
Journal:  Trends Cardiovasc Med       Date:  2008-07       Impact factor: 6.677

7.  Maternal apolipoprotein E genotype as a potential risk factor for poor birth outcomes: The Bogalusa Heart Study.

Authors:  M B Jacobs; E W Harville; T N Kelly; L A Bazzano; W Chen
Journal:  J Perinatol       Date:  2016-02-18       Impact factor: 2.521

8.  Placental secretion of apolipoprotein A1 and E: the anti-atherogenic impact of the placenta.

Authors:  Hassan Melhem; Sampada Kallol; Xiao Huang; Michael Lüthi; Corneille Edgar Ontsouka; Adrian Keogh; Deborah Stroka; Wolfgang Thormann; Henning Schneider; Christiane Albrecht
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

9.  Roles of apolipoprotein E (ApoE) and inducible nitric oxide synthase (iNOS) in inflammation and apoptosis in preeclampsia pathogenesis and progression.

Authors:  Luyi Mao; Qiongjie Zhou; Shufeng Zhou; Rhonda R Wilbur; Xiaotian Li
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.